Patent · US Active

Inhibitors of RET

US10183928B2 · kind B2 · utility

9Cited by
18References
47Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 17, 2017
Grant dateJan 22, 2019
Priority date—
Expiry dateMar 17, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Described herein are compounds that inhibit wild-type RET and its resistant mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.